These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25069632)

  • 1. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.
    Faria R; Gomes M; Epstein D; White IR
    Pharmacoeconomics; 2014 Dec; 32(12):1157-70. PubMed ID: 25069632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.
    Mason AJ; Gomes M; Grieve R; Ulug P; Powell JT; Carpenter J
    Clin Trials; 2017 Aug; 14(4):357-367. PubMed ID: 28675302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial.
    Leurent B; Gomes M; Faria R; Morris S; Grieve R; Carpenter JR
    Pharmacoeconomics; 2018 Aug; 36(8):889-901. PubMed ID: 29679317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missing data in trial-based cost-effectiveness analysis: An incomplete journey.
    Leurent B; Gomes M; Carpenter JR
    Health Econ; 2018 Jun; 27(6):1024-1040. PubMed ID: 29573044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.
    Gabrio A; Mason AJ; Baio G
    Pharmacoecon Open; 2017 Jun; 1(2):79-97. PubMed ID: 29442336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials.
    Manca A; Palmer S
    Appl Health Econ Health Policy; 2005; 4(2):65-75. PubMed ID: 16162026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.
    Cro S; Morris TP; Kahan BC; Cornelius VR; Carpenter JR
    BMC Med Res Methodol; 2020 Aug; 20(1):208. PubMed ID: 32787782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis.
    Leurent B; Gomes M; Cro S; Wiles N; Carpenter JR
    Health Econ; 2020 Feb; 29(2):171-184. PubMed ID: 31845455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials.
    Gomes M; Díaz-Ordaz K; Grieve R; Kenward MG
    Med Decis Making; 2013 Nov; 33(8):1051-63. PubMed ID: 23913915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are missing data adequately handled in cluster randomised trials? A systematic review and guidelines.
    Díaz-Ordaz K; Kenward MG; Cohen A; Coleman CL; Eldridge S
    Clin Trials; 2014 Oct; 11(5):590-600. PubMed ID: 24902924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.
    Song J; Boscardin WJ; Furst DE; Khanna D; Wong WK
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-122-6. PubMed ID: 25372798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis.
    Ling X; Gabrio A; Mason A; Baio G
    Value Health; 2022 Sep; 25(9):1654-1662. PubMed ID: 35341690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.
    Jakobsen JC; Gluud C; Wetterslev J; Winkel P
    BMC Med Res Methodol; 2017 Dec; 17(1):162. PubMed ID: 29207961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing data in trial-based cost-effectiveness analysis: the current state of play.
    Noble SM; Hollingworth W; Tilling K
    Health Econ; 2012 Feb; 21(2):187-200. PubMed ID: 22223561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of missing data in follow-up studies of randomised controlled trials: A systematic review of the literature.
    Sullivan TR; Yelland LN; Lee KJ; Ryan P; Salter AB
    Clin Trials; 2017 Aug; 14(4):387-395. PubMed ID: 28385071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice.
    Ng ES; Diaz-Ordaz K; Grieve R; Nixon RM; Thompson SG; Carpenter JR
    Stat Methods Med Res; 2016 Oct; 25(5):2036-2052. PubMed ID: 24346164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.
    Franklin M; Lomas J; Richardson G
    Pharmacoeconomics; 2020 Jul; 38(7):665-681. PubMed ID: 32291596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation.
    Riley P; Glenny AM; Worthington HV; Jacobsen E; Robertson C; Durham J; Davies S; Petersen H; Boyers D
    Health Technol Assess; 2020 Feb; 24(7):1-224. PubMed ID: 32065109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design and conduct of clinical trials to limit missing data.
    Little RJ; Cohen ML; Dickersin K; Emerson SS; Farrar JT; Neaton JD; Shih W; Siegel JP; Stern H
    Stat Med; 2012 Dec; 31(28):3433-43. PubMed ID: 22829439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.